Krista F.g. Huybrechts, Ph.D.
| Title | Instructor in Medicine |
|---|
| Institution | Brigham and Women's Hospital |
|---|
| Department | Medicine |
|---|
| Address | Brigham and Women's Hospital General Medicine.Pharmocoepidemiology 1620 Tremont St Boston MA 02120
|
|---|
| Phone | 617/278-0930 |
|---|
| Fax | 617/232-8602 |
|---|
|
|
|
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
-
Bateman BT, Hernandez-Diaz S, Huybrechts KF, Palmsten K, Mogun H, Ecker JL, Fischer MA. Patterns of outpatient antihypertensive medication use during pregnancy in a Medicaid population. Hypertension. 2012 Oct; 60(4):913-20.
-
Huybrechts KF, Seeger JD, Rothman KJ, Glynn RJ, Avorn J, Schneeweiss S. Bias in comparative effectiveness studies due to regional variation in medical practice intensity: a legitimate concern, or much ado about nothing? Circ Cardiovasc Qual Outcomes. 2012 Sep 1; 5(5):e61-4.
-
Zoëga H, Rothman KJ, Huybrechts KF, Ólafsson Ö, Baldursson G, Almarsdóttir AB, Jónsdóttir S, Halldórsson M, Hernández-Diaz S, Valdimarsdóttir UA. A population-based study of stimulant drug treatment of ADHD and academic progress in children. Pediatrics. 2012 Jul; 130(1):e53-62.
-
Huybrechts KF, Gerhard T, Crystal S, Olfson M, Avorn J, Levin R, Lucas JA, Schneeweiss S. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ. 2012; 344:e977.
-
Huybrechts KF, Schneeweiss S, Gerhard T, Olfson M, Avorn J, Levin R, Lucas JA, Crystal S. Comparative safety of antipsychotic medications in nursing home residents. J Am Geriatr Soc. 2012 Mar; 60(3):420-9.
-
Huybrechts KF, Rothman KJ, Brookhart MA, Silliman RA, Crystal S, Gerhard T, Schneeweiss S. Variation in antipsychotic treatment choice across US nursing homes. J Clin Psychopharmacol. 2012 Feb; 32(1):11-7.
-
Myers JA, Rassen JA, Gagne JJ, Huybrechts KF, Schneeweiss S, Rothman KJ, Joffe MM, Glynn RJ. Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol. 2011 Dec 1; 174(11):1213-22.
-
Huybrechts KF, Brookhart MA, Rothman KJ, Silliman RA, Gerhard T, Crystal S, Schneeweiss S. Comparison of different approaches to confounding adjustment in a study on the association of antipsychotic medication with mortality in older nursing home patients. Am J Epidemiol. 2011 Nov 1; 174(9):1089-99.
-
Wise LA, Mikkelsen EM, Rothman KJ, Riis AH, Sørensen HT, Huybrechts KF, Hatch EE. A prospective cohort study of menstrual characteristics and time to pregnancy. Am J Epidemiol. 2011 Sep 15; 174(6):701-9.
-
Cosgrove L, Shi L, Creasey DE, Anaya-McKivergan M, Myers JA, Huybrechts KF. Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry. PLoS One. 2011; 6(4):e18210.
-
Huybrechts KF, Rothman KJ, Silliman RA, Brookhart MA, Schneeweiss S. Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. CMAJ. 2011 Apr 19; 183(7):E411-9.
-
Huybrechts KF, Mikkelsen EM, Christensen T, Riis AH, Hatch EE, Wise LA, Sørensen HT, Rothman KJ. A successful implementation of e-epidemiology: the Danish pregnancy planning study 'Snart-Gravid'. Eur J Epidemiol. 2010 May; 25(5):297-304.
-
Caro JJ, Huybrechts KF. Case-control studies in pharmacoeconomic research: an overview. Pharmacoeconomics. 2009; 27(8):627-34.
-
Huybrechts KF, Caro JJ, Xenakis JJ, Vemmos KN. The prognostic value of the modified Rankin Scale score for long-term survival after first-ever stroke. Results from the Athens Stroke Registry. Cerebrovasc Dis. 2008; 26(4):381-7.
-
Huybrechts KF, Caro JJ, O'Brien JA. Prevention and management of hyperphosphatemia with sevelamer in Canada: health and economic consequences. Value Health. 2009 Jan-Feb; 12(1):16-9.
-
Huybrechts KF, Caro JJ. The Barthel Index and modified Rankin Scale as prognostic tools for long-term outcomes after stroke: a qualitative review of the literature. Curr Med Res Opin. 2007 Jul; 23(7):1627-36.
-
Caro JJ, Huybrechts KF, Xenakis JG, O'Brien JA, Rajagopalan K, Lee K. Budgetary impact of treating acute bipolar mania in hospitalized patients with quetiapine: an economic analysis of clinical trials. Curr Med Res Opin. 2006 Nov; 22(11):2233-42.
-
Caro JJ, Xenakis JG, Huybrechts KF. Ignoring study design heterogeneity in meta-analyses. Arch Intern Med. 2006 Oct 9; 166(18):2046; author reply 2046-7.
-
Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone. 2006 Jun; 38(6):922-8.
-
Huybrechts KF, Caro JJ, Wilson DA, O'Brien JA. Health and economic consequences of sevelamer use for hyperphosphatemia in patients on hemodialysis. Value Health. 2005 Sep-Oct; 8(5):549-61.
-
Huybrechts KF, Caro JJ, London GM. Modeling the implications of changes in vascular calcification in patients on hemodialysis. Kidney Int. 2005 Apr; 67(4):1532-8.
-
Caro JJ, Ishak KJ, Huybrechts KF, Raggio G, Naujoks C. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int. 2004 Dec; 15(12):1003-8.
-
Caro J, Huybrechts KF, Klittich WS, Jackson JD, McGuire A. Allocating funds for cardiovascular disease prevention in light of the NCEP ATP III guidelines. Am J Manag Care. 2003 Jul; 9(7):477-89.
-
Ward A, Caro JJ, Green TC, Huybrechts K, Arana A, Wait S, Eleftheriou A. An international survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use. BMC Clin Pharmacol. 2002 Apr 23; 2:3.
-
Caro JJ, Ward A, Green TC, Huybrechts K, Arana A, Wait S, Eleftheriou A. Impact of thalassemia major on patients and their families. Acta Haematol. 2002; 107(3):150-7.
-
Payne KA, Huybrechts KF, Caro JJ, Craig Green TJ, Klittich WS. Long term cost-of-illness in stroke: an international review. Pharmacoeconomics. 2002; 20(12):813-25.
-
Caro JJ, Huybrechts KF, Klittich WS. Secondary prevention fallacy: pitfalls in comparing with primary. Expert Rev Pharmacoecon Outcomes Res. 2001 Oct; 1(1):13-8.
-
Caro JJ, Huybrechts KF, Kelley HE. Predicting treatment costs after acute ischemic stroke on the basis of patient characteristics at presentation and early dysfunction. Stroke. 2001 Jan; 32(1):100-6.
-
Caro JJ, Huybrechts KF, De Backer G, De Bacquer D, Closon MC. Are the WOSCOPS clinical and economic findings generalizable to other populations? A case study for Belgium. The WOSCOPS Economic Analysis Group. West of Scotland Coronary Prevention Study. Acta Cardiol. 2000 Aug; 55(4):239-46.
-
Caro JJ, Huybrechts KF, Duchesne I. Management patterns and costs of acute ischemic stroke : an international study. For the Stroke Economic Analysis Group. Stroke. 2000 Mar; 31(3):582-90.
-
Caro JJ, Huybrechts KF. Stroke treatment economic model (STEM): predicting long-term costs from functional status. Stroke. 1999 Dec; 30(12):2574-9.
This graph shows the total number of publications by year.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
|
Huybrechts's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|